These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 351054)

  • 1. Functional properties of EL-4 tumor cells with lipid-altered membranes.
    Mandel G; Clark W
    J Immunol; 1978 May; 120(5):1637-43. PubMed ID: 351054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of the fatty acid composition of membrane phospholipids in mouse lymphoid cells.
    Mandel G; Shimizu S; Gill R; Clark W
    J Immunol; 1978 May; 120(5):1631-6. PubMed ID: 659868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane structure-function relationships in cell-mediated cytolysis. I. Effect of exogenously incorporated fatty acids on effector cell function in cell-mediated cytolysis.
    Gill R; Clark W
    J Immunol; 1980 Aug; 125(2):689-95. PubMed ID: 6446577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of mammary tumor cells to complement-mediated cytolysis after in vitro or in vivo fatty acid manipulation.
    Erickson KL; Thomas IK
    J Natl Cancer Inst; 1985 Aug; 75(2):333-40. PubMed ID: 3860685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of expression of A cell-surface antigen on activated murine macrophages to tumor cell cytotoxicity.
    Kaplan AM; Bear HD; Kirk L; Cummins C; Mohanakumar T
    J Immunol; 1978 Jun; 120(6):2080-5. PubMed ID: 659893
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipid modulation of mammary tumor cell cytolysis: direct influence of dietary fats on the effector component of cell-mediated cytotoxicity.
    Thomas IK; Erickson KL
    J Natl Cancer Inst; 1985 Mar; 74(3):675-80. PubMed ID: 3871875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fatty acid modifications of cultured hepatoma cells on susceptibility to complement-mediated cytolysis.
    Yoo TJ; Chiu HC; Spector AA; Whiteaker RS; Denning GM; Lee NF
    Cancer Res; 1980 Apr; 40(4):1084-90. PubMed ID: 7357539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated lymphoid cells: analysis of host cells that bind to syngeneic and allogeneic tumor cells shortly after tumor administration.
    Schick B; Berke B
    Transplant Proc; 1977 Mar; 9(1):1157-60. PubMed ID: 867485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acid modification of membrane structure and function. II. Alteration by docosahexaenoic acid of tumor cell sensitivity to immune cytolysis.
    Pascale AW; Ehringer WD; Stillwell W; Sturdevant LK; Jenski LJ
    Nutr Cancer; 1993; 19(2):147-57. PubMed ID: 8502585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cell-mediated cytotoxicity function after alteration of fatty acid composition in vitro.
    Bialick R; Gill R; Berke G; Clark WR
    J Immunol; 1984 Jan; 132(1):81-7. PubMed ID: 6197462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
    Dennert G; Hatlen LE
    J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cell destruction by cytotoxic T lymphocytes: the basis of reduced antitumor cell activity in syngeneic hosts.
    Fishelson Z; Berke G
    J Immunol; 1981 May; 126(5):2048-52. PubMed ID: 6783702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
    Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H
    Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of IgH V-region genes on the growth kinetics of a murine B cell leukemia (BCL1).
    Ciavarra R; Forman J
    J Immunol; 1981 Jan; 126(1):54-8. PubMed ID: 6778917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of the cytotoxic effect of tumor cells against the targets of normal killers].
    Fuks BB; Zedginidze MS; Spirande IV; Kogarko IN; Sterlina AG
    Biull Eksp Biol Med; 1981 Sep; 92(9):342-5. PubMed ID: 7295991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of homology in the JC subregion of the H2 complex in the reciprocal suppression of normal killer and tumor cells].
    Zedginidze MS; Spirande IV; Nikonenko BV; Fuks BB
    Biull Eksp Biol Med; 1982 Apr; 93(4):82-5. PubMed ID: 7082810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
    Engers HD; Lahaye T; Sorenson GD; Glasebrook AL; Horvath C; Brunner KT
    J Immunol; 1984 Sep; 133(3):1664-70. PubMed ID: 6205090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic granules from killer cells: specificity of granules and insertion of channels of defined size into target membranes.
    Criado M; Lindstrom JM; Anderson CG; Dennert G
    J Immunol; 1985 Dec; 135(6):4245-51. PubMed ID: 2415607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in cellular lipid synthesis of normal and neoplastic cells during cytolysis induced by alkyl lysophospholipid analogues.
    Herrmann DB
    J Natl Cancer Inst; 1985 Sep; 75(3):423-30. PubMed ID: 3861897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.